Retrograde delivery of stem cells: Promising delivery strategy for myocardial regenerative therapy

Clinical Transplantation

Volumn 25, Issue 6, 2011, Pages 830-833

  Wu, Kaihong ^a   Mo, Xuming ^a   Lu, Shihong ^b   Han, Zhongchao ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Cell delivery; Cell transplantation; Coronary vein; Myocardial infarction; Stem cells

Indexed keywords

CORONARY ARTERY COLLATERAL CIRCULATION; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART INJURY; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION;

DRUG DELIVERY SYSTEMS; HUMANS; MYOCARDIAL ISCHEMIA; REGENERATION; STEM CELL TRANSPLANTATION;

EID: 83555160838     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2011.01508.x     Document Type: Review

References (21)

1. Passier R, Van Laake LW, Mummery CL. Stem-cell-based therapy and lessons from the heart. Nature 2008: 453: 322.
2. Wu KH, Liu YL, Zhou B, Han ZC. Cellular therapy and myocardial tissue engineering: the role of adult stem and progenitor cells. Eur J Cardiothorac Surg 2006: 30: 770.
3. Zhang H, Wei YJ, Hu SS. Intraoperative cell transplantation for congestive heart failure: experience in China. Semin Thorac Cardiovasc Surg 2008: 20: 126.
4. Orlic D, Kajstura J, Chimenti S et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001: 410: 701.
5. Murry CE, Soonpaa MH, Reinecke H et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004: 428: 664.
6. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004: 428: 668.
7. Uemura R, Xu M, Ahmad N, Ashraf M. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res 2006: 98: 1414.
8. Wu KH, Zhou B, Yu CT et al. Therapeutic potential of human umbilical cord derived stem cells in a rat myocardial infarction model. Ann Thorac Surg 2007: 83: 1491.
9. Wu KH, Mo XM, Zhou B et al. Cardiac potential of stem cells from whole human umbilical cord tissue. J Cell Biochem 2009: 107: 926.
10. Barbash IM, Chouraqui P, Baron J et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 2003: 108: 863.
11. Yousef M, Schannwell CM, Kostering M, Zeus T, Brehm M, Strauer BE. The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction. J Am Coll Cardiol 2009: 53: 2262.
12. Zhang H, Song P, Tang Y et al. Injection of bone marrow mesenchymal stem cells in the borderline area of infarcted myocardium: heart status and cell distribution. J Thorac Cardiovasc Surg 2007: 134: 1234.
13. Baklanov DV, Moodie KM, McCarthy FE et al. Comparison of transendocardial and retrograde coronary venous intramyocardial catheter delivery systems in healthy and infarcted pigs. Catheter Cardiovasc Interv 2006: 68: 416.
14. Vicario J, Piva J, Pierini A et al. Transcoronary sinus delivery of autologous bone marrow and angiogenesis in pig models with myocardial injury. Cardiovasc Radiat Med 2002: 3: 91.
15. Thompson CA, Nasseri BA, Makower J et al. Percutaneous transvenous cellular cardiomyoplasty. A novel nonsurgical approach for myocardial cell transplantation. J Am Coll Cardiol 2003: 41: 1964.
16. Yokoyama S, Fukuda N, Li Y et al. A strategy of retrograde injection of bone marrow mononuclear cells into the myocardium for the treatment of ischemic heart disease. J Mol Cell Cardiol 2006: 40: 24.
17. Suzuki K, Murtuza B, Fukushima S et al. Targeted cell delivery into infarcted rat hearts by retrograde intracoronary infusion: distribution, dynamics, and influence on cardiac function. Circulation 2004: 110: II225.
18. Sato T, Iso Y, Uyama T et al. Coronary vein infusion of multipotent stromal cells from bone marrow preserves cardiac function in swine ischemic cardiomyopathy via enhanced neovascularization. Lab Invest 2011: 91: 553.
19. Fukushima S, Coppen SR, Lee J et al. Choice of cell-delivery route for skeletal myoblast transplantation for treating post-infarction chronic heart failure in rat. PLoS ONE 2008: 3: e3071.
20. Hou D, Youssef EA, Brinton TJ et al. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation 2005: 112: I150.
21. Vicario J, Campo C, Piva J et al. One-year follow-up of transcoronary sinus administration of autologous bone marrow in patients with chronic refractory angina. Cardiovasc Revasc Med 2005: 6: 99.